During the past decade, McCabe Vision Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "McCabe Vision Center" are "Blepharitis" (1 trials) and "Eye Allergies" (1 trials). Many other conditions were trialed in "McCabe Vision Center" in a lesser frequency.

Most popular intervention types in "McCabe Vision Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Azithromycin ophthalmic solution, 1%" (1 trials), "Bepotastine besilate ophthalmic solution 1.5%" (1 trials), "Olopatadine hydrochloride 0.2%" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "McCabe Vision Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "McCabe Vision Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in McCabe Vision Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in McCabe Vision Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".